Results 111 to 120 of about 5,966,929 (265)

Inflammatory biomarker panels in peripheral blood: association with myasthenia gravis onset and severity

open access: yesFrontiers in Neurology
ObjectiveTo investigate the association between peripheral blood inflammatory biomarkers and the clinical phenotypes, severity, and prognosis of myasthenia gravis (MG).MethodsThis retrospective study analyzed 134 MG patients (including 23 with myasthenic
Hong Jin   +8 more
doaj   +1 more source

Neurovascular Contacts in the Pathophysiology of Neuralgic Amyotrophy: An Observational Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuralgic amyotrophy (NA) is a prevalent, monophasic, multifocal immune‐mediated neuropathy. A distinctive characteristic of the disease is the occurrence of nerve or fascicle constrictions and torsions (NA‐associated focal nerve lesions, NAFL). The pathophysiology underlying this phenomenon remains to be fully elucidated.
Johannes Fabian Holle   +4 more
wiley   +1 more source

Cognitive impairment in Behcet’s disease patients without overt neurological involvement

open access: yes, 2004
We investigated the prevalence of cognitive impairment in patients with Behc ̧et’s disease (BD) without overt neurological involvement. The influence of disease duration, disease activity, prednisone dosage, and anxiety and depression levels was ...
MONASTERO, Roberto   +8 more
core   +1 more source

Validation and Functional Exploration of Exosome-Derived ITGA9-AS1 and WNT5A-AS1 as Candidate Diagnostic Biomarkers for Schizophrenia

open access: yesNeuropsychiatric Disease and Treatment
Yangyang Xu,1,2,* Yan Wang,3,* Fuyi Qin,4 Ling Yu,1 Weihao Li,1 Xu You,5 Li Guo,5 Yilin Liu,1 Yong Zeng1 1Key Laboratory of Neurological and Psychiatric Disease Research of Yunnan Province, The Second Affiliated Hospital of Kunming ...
Xu Y   +8 more
doaj  

Efficacy and safety of cell-based therapies for drug-resistant epilepsy: a systematic review of human studies

open access: yesEuropean Journal of Medical Research
Introduction Drug-resistant epilepsy affects roughly one-third of people with epilepsy and carries substantial morbidity and mortality. Cell-based therapies are hypothesized to modulate neuroinflammation and network dysfunction.
Amirali Latifian   +7 more
doaj   +1 more source

Association Between Motor Pathway Damage and Motor Deficit in Upper and Lower Limb in People With MS

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corticospinal tract damage is common in people with MS, but the degree of clinical symptoms varies. We hypothesize that corticospinal tract lesions are more extensive and severe in people with MS with motor impairments in both upper and lower limbs.
Mathilde Liffran   +13 more
wiley   +1 more source

Nosocomial Infections in a Neurological Intensive Care Unit

open access: yes, 2009
Background: Nosocomial infections in intensive care units are common and associated with high morbidity, mortality. This study was planned to evaluate the occurance and causes of site specific nosocomial infections in a neurological intensive care unit ...
Biyikli, Bilge   +6 more
core  

Celiac Disease and Neurological Symptoms [PDF]

open access: yes, 2013
New research has revealed that Celiac disease, an autoimmune illness affecting the small intestine, has more ties with neurological side effects than once was thought.
Cook, Lauren V.
core   +1 more source

Spatial and Volumetric Characteristics of Glioblastoma: Associations With Clinical Presentation and Survival

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou   +16 more
wiley   +1 more source

Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Autoimmune autonomic ganglionopathy (AAG) is a rare but potentially treatable cause of severe autonomic failure. Evidence guiding long‐term immunotherapy, treatment sequencing, and residual autonomic impairment is limited. We evaluated long‐term treatment response, residual autonomic dysfunction, and relapse patterns in patients with
Giacomo Chiaro   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy